Propagenix is a preclinical-stage platform technology company that is applying its unique technology to both internal and partnered cell therapy programs. The company is engaged in the development and commercialization of technology which originated from the laboratory of Dr. Richard Schlegel of Georgetown University.
Longeveron Wins $6.7 Million in Grant Funding, Including a $750,000 MSCRF Award
Longeveron LLC is a regenerative medicine company developing cellular solutions for aging-related diseases. The company is focused on the development of allogeneic (donor-derived) human mesenchymal stem cells (MSCs) that are harvested and grown at its manufacturing facility in Miami, Florida.
Longeveron’s MSC (LMSC) product is derived from the bone marrow of young, healthy adult donors.
In addition to manufacturing its own cells in this cGMP facility, Longeveron is conducting clinical trials and manufacturing cells for other parties through its cell therapy CMO business. A contract manufacturing organization (CMO) is a company that provides manufacturing services to cell and gene therapy companies on a contract basis. [Read more…]